You are here: Industry Insights > cancer

News List

When a cell's 'fingerprint' can be a weapon against cancer worldpharmanews
March 14, 2019
The study published in the scientific journal PLoS Computational Biology shows the types of tumors in which these genes are most active and identifies drugs with the potential to selectively eliminate cells that carry that label.
Cellectis to Build Mfg. Facility in North Carolina contractpharma
March 13, 2019
With help from CMO partners, advances further towards commercialization of UCART portfolio
A third cancer-causing impurity detected in U.S. supply of blood pressure drug fiercepharma
March 08, 2019
Just when it appeared the FDA was close to purging the U.S. drug supply of potential cancer-causing impurities in sartan blood pressure drugs, another massive recall has been launched. This time it is for an entirely new contaminant.
Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer en-cphi.cn
March 07, 2019
The second Phase 3 study initiation announcement made during the International HPV Awareness Day
‘Smart drug’ shows promise for metastatic triple-negative breast cancer europeanpharmaceuticalreview
February 22, 2019
A study has shown that a ‘smart drug’ that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer…
Keytruda gets okay from FDA for adjuvant melanoma pharmaphorum
February 21, 2019
The US FDA has approved Merck & Co’s Keytruda as an adjuvant treatment for patients with melanoma who have had surgery but still show some evidence of cancer in their lymph nodes.
Sales of generic oncology drugs surge europeanpharmaceuticalreview
February 21, 2019
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028…
USPSTF Says Screen Women With Higher Risk for BRCA Mutations drugs
February 20, 2019
The U.S. Preventive Services Task Force (USPSTF) recommends screening for women at increased risk for carrying a BRCA1/2mutation as well as genetic counseling and testing as indicated for those screening positive.
Two new cancer Priority Reviews for Roche pharmaphorum
February 20, 2019
Roche has announced that the FDA has granted Priority Review to two of its drugs – personalised lung cancer medicine entrectinib and lymphoma treatment polatuzumab vedotin.
Researchers develop reversible antiplatelet therapy to fight clotting, cancer metastasis worldpharmanews
February 18, 2019
A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page